First Horizon Advisors’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$32.8K Buy
548
+35
+7% +$1.92K ﹤0.01% 1223
2025
Q1
$26.9K Buy
513
+226
+79% +$12.7K ﹤0.01% 1202
2024
Q4
$15.8K Hold
287
﹤0.01% 1422
2024
Q3
$14.4K Hold
287
﹤0.01% 1501
2024
Q2
$12.6K Buy
287
+9
+3% +$383 ﹤0.01% 1438
2024
Q1
$12.2K Buy
+278
New +$12.3K ﹤0.01% 1517

Other funds holding IRMD

First Horizon Advisors's IRMD Position: Q2 2025 in Review

First Horizon Advisors increased its iRadimed (IRMD) stake by 6.8% in Q2 2025, buying an estimated $1.92K and bringing the position to 548 shares worth $32.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1223.

First Horizon Advisors first reported a position in IRMD in Q1 2024 and has held it in 6 quarters since. 162 funds tracked by Wall St. Rank hold IRMD as of Q2 2025.

  • First Horizon Advisors held 548 shares of iRadimed worth $32.8K as of Q2 2025.
  • First Horizon Advisors bought 35 iRadimed shares in Q2 2025, an estimated $1.92K.
  • iRadimed made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1223 holding.
  • First Horizon Advisors first reported a position in iRadimed in Q1 2024 and has held it in 6 quarters since.
  • 162 funds tracked by Wall St. Rank held iRadimed as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.